M8J-38413-17865
3 vaccinations
3 coded responses
32 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 207 / MD
- Registered
- 2021-02-22
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-21
Dose 1 — Moderna
-
2021-02-22
Registered in v-safe
-
2021-02-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-07
- 2021-03-14
-
2021-03-21
Dose 2 — Moderna
- 2021-03-21
- 2021-03-22
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: GoodFree text: I have asthma, severe obesity, and anemiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-18
- 2021-04-27
- 2021-05-02
-
2021-06-20
Survey response — 3 months, dose 2MedDRA: Asthma — Feeling: Good · Be unable to do your normal daily activitiesFree text: Had an asthma attackMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-19
-
2021-10-13
Dose 3 — Pfizer-BioNTech
- 2021-10-28
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2021-11-24
- 2022-01-12
- 2022-04-13
-
2022-10-13
Survey response — 12 months, dose 3MedDRA: Diabetes mellitus, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Diabetes, allergiesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-21 | Moderna | |
| 2 | 2021-03-21 | Moderna | |
| 3 | 2021-10-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): I have asthma, severe obesity, and anemia
Release 9 — 3 months, dose 2
Symptoms: Had an asthma attack
Release 12 — 12 months, dose 3
Symptoms: Diabetes, allergies
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Diabetes mellitus | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release